Eriko Iguchi
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Hepatitis C virus research 4
-
- Liver Disease Diagnosis and Treatment 7
- Hepatitis B Virus Studies 4
- Co-authors
- Haruhiko Takeda (22 shared papers)Ryuichi Kita (11 shared papers)Yukio Osaki (11 shared papers)Tōru Kimura (11 shared papers)Hiroki Nishikawa (10 shared papers)Azusa Sakamoto (9 shared papers)Sumio Saito (9 shared papers)Keiichi Hatamaru (7 shared papers)
- Journals
- Scientific Reports (3 papers)The Journal of Pathology (2 papers)Hepatology Research (2 papers)Journal of Hepato-Biliary-Pancreatic Sciences (2 papers)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Eriko Iguchi
27 papers receiving 331 citations
Peers
Comparison fields: 5 of 52
- Hepatology 219
- Epidemiology 162
- Cancer Research 54
- Oncology 57
- Pathology and Forensic Medicine 31
Countries citing papers authored by Eriko Iguchi
This map shows the geographic impact of Eriko Iguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Iguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Iguchi more than expected).
Fields of papers citing papers by Eriko Iguchi
This network shows the impact of papers produced by Eriko Iguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Iguchi. The network helps show where Eriko Iguchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Eriko Iguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 40 | |
| 2 | 2012 | 35 | |
| 3 | Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients. | 2012 | 26 |
| 4 | 2013 | 22 | |
| 5 | 2020 | 21 | |
| 6 | 2012 | 20 | |
| 7 | 2012 | 19 | |
| 8 | Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language. | 2016 | 18 |
| 9 | 2012 | 16 | |
| 10 | 2015 | 16 | |
| 11 | 2019 | 16 | |
| 12 | Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma. | 2012 | 15 |
| 13 | 2012 | 14 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2020 | 5 |
About Eriko Iguchi
Eriko Iguchi is a scholar working on Hepatology, Epidemiology, Cancer Research, Oncology and Surgery, having authored 28 papers that have together received 337 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Liver Disease Diagnosis and Treatment (7 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cancer Research and Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Hepatology (219 citations), Epidemiology (162 citations), Cancer Research (54 citations), Oncology (57 citations) and Pathology and Forensic Medicine (31 citations). Eriko Iguchi has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Haruhiko Takeda, Ryuichi Kita, Yukio Osaki, Tōru Kimura, Hiroki Nishikawa, Azusa Sakamoto, Sumio Saito, Keiichi Hatamaru, Akihiro Nasu and Fumihiro Matsuda. Their work appears in journals such as Scientific Reports, The Journal of Pathology, Hepatology Research, Journal of Hepato-Biliary-Pancreatic Sciences and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.